http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1237625-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6467603a8a93d373127419274261d8c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0651
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0642
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0648
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-20
filingDate 2000-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c3bc4eb90adaa0ba6108557c3e8233e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_712a2d010e7a3b8d5ea5f7f4d0f83c0e
publicationDate 2002-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1237625-A1
titleOfInvention Illuminating device for treating eye disease
abstract A photodynamic therapy (PDT) device (20) utilizes a non-coherent light source (22) to activate a photoreactive agent for treating a diseased site in a patient's eye (10). When activated, the photoreactive agent causes a desired change in the diseased tissue of the treatment site. In one embodiment, the photoreactive agent is preferentially absorbed by the diseased tissue at the treatment site, and the light from the PDT device (20) is directed generally at the site. In another embodiment, the photoreactive agent is less selectively absorbed by the diseased tissue, and the light from the PDT device (20) is focused onto the diseased treatment site. The device preferably focuses the light emitted by a source using totally internally reflective (TIR) lenses (14), convergent lenses (24), divergent lenses, and/or deformable lenses. One embodiment incorporates a plurality of light sources of different wavebands, including a waveband that does not activate the photoreactive agent, so that the light source can be used to precisely target the focal point at the desired treatment site. Once targeted, a light source is energized to produce light in a waveband that activates the photoreactive agent and can penetrate different depths of tissue. The PDT device (20) can be incorporated into a headset or in an ophthalmic slit lamp.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110507912-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110507912-A
priorityDate 1999-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4858609-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5137018-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9010473-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397752
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57184418
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11980904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282412
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136090971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397753

Total number of triples: 31.